In this Psychiatric Times Peer Exchange, the panel delves into a comprehensive examination of schizophrenia care, covering the clinical and economic burden of the disease, the multifactorial challenges of treatment adherence, and the evolving landscape of pharmacological options — from first-generation antipsychotics to novel mechanisms of action and alternative delivery systems. The series emphasizes the critical importance of early intervention, patient empowerment, multidisciplinary collaboration, and systemic reform in closing the gap between available evidence and real-world outcomes for patients living with schizophrenia.
-
COMP360 Psilocybin in Treatment-Resistant Depression: Insights From Gus Alva, MD, DFAPA
Author(s)Gustavo Alva, MD, DFAPA Phase 3 COMP360 psilocybin data show lasting TRD relief; experts explain brain-network reset, therapy support, and what approval could mean. View video on YouTube Gus Alva, MD, discussed the current state of psychedelic research in psychiatry, with particular…
-
Starting ADHD Treatment in Adolescents, With Ann Childress, MD
Author(s)Gustavo Alva, MD, DFAPA, Ann Childress, MD Expert shares ADHD medication sequencing tips and practical insomnia strategies, from stimulants to melatonin, for kids and adults. View video on YouTube Ann Childress, MD, discussed clinical approaches to medication sequencing in attention-deficit hyperactivity disorder…